Literature DB >> 18084692

Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.

Jukka P Rissanen1, Mari I Suominen, Zhiqi Peng, Jussi M Halleen.   

Abstract

PURPOSE: To study the effects of estrogen withdrawal on osteoclast number and osteoclast activity in the rat ovariectomy (OVX) model.
METHODS: We first cultured human CD34+ osteoclast precursor cells on bovine bone slices, allowing them to differentiate into mature resorbing osteoclasts. Secreted tartrate-resistant acid phosphatase 5b (TRACP 5b) and C-terminal cross-linked telopeptides of type I collagen (CTX) were determined from the culture medium. TRACP 5b correlated strongly with osteoclast number and CTX with osteoclast activity, facilitating their subsequent use in the rat OVX model. An 8 week OVX study was then performed including sham-operated rats receiving vehicle, OVX rats receiving vehicle, and OVX rats receiving 10 microg/kg/day 17 beta-estradiol (E2). Trabecular bone parameters were determined from the tibial metaphysis using peripheral quantitative computed tomography and histomorphometry. Osteoclast number was normalized with bone perimeter (N.Oc/B.Pm) and tissue area (N.Oc/T.Ar, indicating absolute number of osteoclasts). TRACP 5b and CTX were determined from fasting serum samples.
RESULTS: Trabecular bone parameters indicated substantial bone loss after OVX that was prevented by E2. N.Oc/B.Pm increased after OVX, while N.Oc/T.Ar and TRACP 5b decreased, and TRACP 5b correlated strongly with N.Oc/T.Ar. However, CTX values increased after OVX, and the "resorption index" CTX/TRACP 5b showed more substantial changes than either CTX or TRACP 5b alone.
CONCLUSION: These results show that TRACP 5b is a reliable marker of osteoclast number, and the index CTX/TRACP 5b is a useful parameter in rat OVX model. The high elevation of CTX/TRACP 5b values by OVX demonstrates that estrogen withdrawal generates high activity of osteoclasts in the rat OVX model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18084692     DOI: 10.1007/s00223-007-9091-4

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  53 in total

1.  Quantitative trait locus on chromosome X affects bone loss after maturation in mice.

Authors:  Shuzo Okudaira; Motoyuki Shimizu; Bungo Otsuki; Rika Nakanishi; Akira Ohta; Keiichi Higuchi; Masanori Hosokawa; Tadao Tsuboyama; Takashi Nakamura
Journal:  J Bone Miner Metab       Date:  2010-03-31       Impact factor: 2.626

2.  The skeletal impact of the chemotherapeutic agent etoposide.

Authors:  A J Koh; B P Sinder; P Entezami; L Nilsson; L K McCauley
Journal:  Osteoporos Int       Date:  2017-04-20       Impact factor: 4.507

3.  Lentivirus transduction of human osteoclast precursor cells and differentiation into functional osteoclasts.

Authors:  Margaret L Ramnaraine; Wendy E Mathews; Denis R Clohisy
Journal:  Bone       Date:  2011-10-01       Impact factor: 4.398

4.  Acute bone changes after lower limb amputation resulting from traumatic injury.

Authors:  D A Bemben; V D Sherk; W J J Ertl; M G Bemben
Journal:  Osteoporos Int       Date:  2017-04-01       Impact factor: 4.507

5.  Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo.

Authors:  Lei Wang; Bin Fang; Toshifumi Fujiwara; Kimberly Krager; Akshita Gorantla; Chaoyuan Li; Jian Q Feng; Michael L Jennings; Jian Zhou; Nukhet Aykin-Burns; Haibo Zhao
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

6.  Acute bone marker responses to whole-body vibration and resistance exercise in young women.

Authors:  Vanessa D Sherk; Carmen Chrisman; Jessica Smith; Kaelin C Young; Harshvardhan Singh; Michael G Bemben; Debra A Bemben
Journal:  J Clin Densitom       Date:  2012-08-16       Impact factor: 2.617

7.  Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.

Authors:  Anita V Neutzsky-Wulff; Mette G Sørensen; Dino Kocijancic; Diana J Leeming; Morten H Dziegiel; Morten A Karsdal; Kim Henriksen
Journal:  BMC Musculoskelet Disord       Date:  2010-06-01       Impact factor: 2.362

8.  Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats.

Authors:  Akishige Hokugo; Shuting Sun; Sil Park; Charles E McKenna; Ichiro Nishimura
Journal:  Bone       Date:  2012-12-04       Impact factor: 4.398

9.  Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.

Authors:  Marion David; Irma Machuca-Gayet; Junichi Kikuta; Penelope Ottewell; Fuka Mima; Raphael Leblanc; Edith Bonnelye; Johnny Ribeiro; Ingunn Holen; Rùben Lopez Vales; Pierre Jurdic; Jerold Chun; Philippe Clézardin; Masaru Ishii; Olivier Peyruchaud
Journal:  J Biol Chem       Date:  2014-01-15       Impact factor: 5.157

10.  Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study.

Authors:  Douglas C Bauer; Patrick Garnero; Stephanie L Harrison; Jane A Cauley; Richard Eastell; Kris E Ensrud; Eric Orwoll
Journal:  J Bone Miner Res       Date:  2009-12       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.